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Diffusion-Weighted Imaging and Cognition in the
Leukoariosis and Disability in the Elderly Study
Reinhold Schmidt, MD; Stefan Ropele, PhD; Jose´ Ferro, MD, PhD; Sofia Madureira, PSyD;
Ana Verdelho, MD; Katja Petrovic, MSc; Alida Gouw, MD; Wiesje M. van der Flier, MD;
Christian Enzinger, MD; Leonardo Pantoni, MD, PhD; Domenico Inzitari, MD;
Timo Erkinjuntti, MD, PhD; Philip Scheltens, MD, PhD; Lars O. Wahlund, MD, PhD;
Gunhild Waldemar, MD, DMSc; Egill Rostrup, MD, MSc; Anders Wallin, MD, PhD;
Frederik Barkhof, MD, PhD; Franz Fazekas, MD; on behalf of the LADIS study group
Background and Purpose—The mechanisms by which leukoariosis impacts on clinical and cognitive functions are not yet
fully understood. We hypothesized that ultrastructural abnormalities of the normal-appearing brain tissue (NABT)
assessed by diffusion-weighted imaging played a major and independent role.
Methods—In addition to a comprehensive clinical, neuropsychologic, and imaging work-up, diffusion-weighted imaging
was performed in 340 participants of the multicenter leukoariosis and disability study examining the impact of white
matter hyperintensities (WMH) on 65- to 85-year old individuals without previous disability. WMH severity was rated
according to the Fazekas score. Multivariate regression analysis served to assess correlations of histogram metrics of the
apparent diffusion coefficient (ADC) of whole-brain tissue, NABT, and of the mean ADC of WMH with cognitive
functions.
Results—Increasing WMH scores were associated with a higher frequency of hypertension, a greater WMH volume, more
brain atrophy, worse overall cognitive performance, and changes in ADC. We found strong associations between the
peak height of the ADC histogram of whole-brain tissue and NABT with memory performance, executive dysfunction,
and speed, which remained after adjustment for WMH lesion volume and brain atrophy and were consistent among
centers. No such association was seen with the mean ADC of WMH.
Conclusions—Ultrastructural abnormalities of NABT increase with WMH severity and have a strong and independent
effect on cognitive functions, whereas diffusion-weighted imaging metrics within WMH have no direct impact. This
should be considered when defining outcome measures for trials that attempt to ameliorate the consequences of WMH
progression. (Stroke. 2010;41:e402-e408.)
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There is abundant evidence for a predominantly vascularetiology of leukoariosis in the elderly population, yet the
role of white matter damage as a contributor to cognitive
impairment and dementia is still not fully determined.1
Cross-sectional and longitudinal studies in patients with
leukoariosis report modest correlations between T2-lesion
load and severity of cognitive impairment on a group level,2–5
but individual patients can have widespread white matter
damage on MRI without any cognitive dysfunction. In this
context, it has to be considered that high signal intensity on
standard MRI can reflect a spectrum of pathological abnor-
malities ranging from very mild tissue changes seen with
punctate lesions to complete demyelination and axonal loss in
the presence of small-vessel disease often seen with confluent
abnormalities.6 Thus, imaging techniques that allow a more
direct assessment of the composition and integrity of white
matter structures are promising tools to explain impaired
cognition related to white matter abnormalities beyond what
can be expected from lesion volumetry. One of these tech-
niques is diffusion-weighted imaging (DWI).
In DWI, the average apparent diffusion coefficient (ADC),
or mean diffusivity, represents a measure of tissue water
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mobility that depends on the structural barriers at cellular and
subcellular levels.7 Pathological processes that modify tissue
integrity such as small-vessel disease are accompanied by an
elevated ADC.7 It has been suggested that in subjects with
age-related white matter hyperintensities (WMH), an increase
in ADC occurs not only in areas of T2 hyperintensity but also
in normal-appearing white matter. Furthermore, mean diffu-
sivity of normal-appearing white matter appeared more
closely related to clinical deficits than the volume of visible
white matter damage.8–13 Such data have been reported in
patients in CADASIL,8 which is a genetic model of rapidly
progressive small-vessel disease, and in single-center studies
of individuals with age-related WMH.9–13
Our study extends previous work by using a multicenter
approach and stratification for the severity of WMH to recruit
a large sample of subjects with a wide range of white matter
damage. We hypothesized that mean diffusivity in WMH and
normal-appearing brain tissue (NABT) affects functioning in
various cognitive domains and that these effects are indepen-
dent of vascular risk factors, white matter lesion volume, and
brain atrophy.
Subjects and Methods
Subjects
All subjects were participants of the multicenter leukoariosis and
disability (LADIS) study. The rationale and design of the LADIS
study have been described elsewhere.14 In summary, elderly subjects
between the ages of 65 and 84 years with MRI evidence of WMH but
no or only mild disability according to the Instrumental Activities of
Daily Living Scale15 were enrolled in a hospital-based setting. To
achieve a well-distributed range of WMH severity we stratified
participants according to the modified Fazekas scale16 with WMH
categorization into 3 severity classes, ie, punctate, early confluent,
and confluent. Further inclusion criteria were the presence of a
regularly contactable informant and the agreement to sign an
informed consent form. Exclusion criteria were likelihood of drop-
ping out because of the presence of severe illnesses, eg, cardiac,
hepatic, or renal failure, cancer, or other relevant systemic diseases;
severe unrelated neurological diseases; leukoencephalopathy of non-
vascular origin (immunologic, demyelinating, metabolic, toxic, in-
fectious, other); severe psychiatric disorders; inability to give in-
formed consent; and inability or refusal to undergo cerebral MRI.
For assessment of vascular risk factors at baseline, a structured
data questionnaire was used together with a review of available
records by trained medical personnel.14 The risk factors used in this
work were patient age, gender, presence of hypertension (treatment
with antihypertensive medications or with values 140/90 mm Hg
based on measurements taken on several separate occasions), history
of diabetes mellitus (treatment with antidiabetic medications or at
least 8-hour fasting plasma glucose 7.0 mmol/L or 126 mg/dL),
atrial fibrillation (based on history or available clinical records such
as an ECG), and history of myocardial infarction (documented by
history, ECG, or cardiac enzymes). Years of education were also
recorded.
MRI
Eight of the 11 LADIS centers participated in this substudy that
required the acquisition of DWI in addition to the general scanning
protocol used in the LADIS study. DWI was optional and some
LADIS centers were not capable of performing a DWI sequence. In
all centers contributing to the current study, imaging was performed
on 1.5-T whole-body systems (ACS-Intera, Philips Medical Sys-
tems; Magnetom Vision, Siemens Medical Systems; Magnetom
Sonata, Siemens Medical Systems; Signa, General Electric Medical
System). The general MRI protocol included the following se-
quences: T1-weighted 3-dimensional magnetization-prepared rapid-
acquisition gradient-echo (scan parameters, coronal or sagittal plane;
echo time, 2–7 ms; repetition time, 9–26 ms; flip angle, 15°–30°;
voxel size, 1111.5 mm3), T2-weighted fast-spin echo (scan
parameters, axial plane; echo time, 100–130 ms; repetition time,
4000–6600 ms; voxel size, 115 mm3; 19–31 slices), and
fluid-attenuated inversion recovery (FLAIR; scan parameters, axial
plane; echo time, 100–140 ms; repetition time, 6000–10 000 ms;
inversion time, 2000–2400; voxel size, 115 mm3; 19–31 slices).
DWI was performed with a pulsed gradient spin-echo sequence
with echo planar imaging readout (repetition time, 4000–6000 ms;
echo time, 100–140 ms; matrix, 128128; field of view, 250 mm;
slice thickness, 5 mm; number of slices, 20–28). The voxel size was
1.951.955 mm and it was identical across all centers.
The sequence was performed with 2 b factors (b0 sec/mm2 and
b900–1000 sec/mm2), whereas the diffusion gradients were ap-
plied along the 3 principal directions. To provide ADC maps of
comparable quality, every participating center was asked to optimize
the protocol within the narrow frame of the proposed parameters
according to local capabilities. Local variations of the DWI protocol
mostly affected the repetition time, sampling bandwidth, partial
Fourier imaging, and the number of averages. The total acquisition
time of the DWI sequence varied as a function of the repetition time
and the number of averages but was 2 minutes in each center.
The slices of all axial sequences were positioned to cover the
central part of the brain and to run parallel to a line defined by the
most inferior–anterior part of the corpus callosum and the most
inferior–posterior part of the corpus callosum.
Image Analysis
Assessment of WMH severity used for this study was performed
centrally by a single rater who was blinded to all clinical informa-
tion. WMH were rated visually on axial FLAIR images using a
modification of the Fazekas scale.16 This scale grades WMH severity
into mild, moderate, and severe categories. Typical examples for
each grade have been displayed elsewhere.17 To determine the
intrarater reliability of this rating scheme, 18 randomly selected
scans were scored twice, which resulted in a weighted Cohen  of
0.84.
In addition to WMH rating, volumetric analysis of WMH was also
performed centrally on the axial FLAIR images. Using a seed-
growing technique with local thresholding, the contour of WMH was
delineated and WMH masks and corresponding volumes were
calculated.18
DWI metrics were analyzed for the whole-brain tissue (WBT),
which included normal-appearing white matter, white matter lesions
and gray matter, the NABT including normal-appearing white matter
and gray matter but no white matter lesions, and areas of WMH.
Because WMH were identified on FLAIR images, all parameter
maps were registered with the FLAIR images after they had been
calculated from the raw data.
To calculate ADC maps, the images with the high b values were
averaged over all 3 principal directions to obtain a rotationally
invariant image. The ADC was then determined by the slope of
the line, which was defined by the natural logarithm of the
averaged image with the high b value and the logarithm of the
T2-weighted image (b0 sec/mm2). The ADC maps were then
registered with the FLAIR scans, and the T2-weighted scan (b0
sec/mm2) was used to calculate the transformation matrix. Reg-
istration was performed with an affine 12-parameter model using
a correlation ratio-based cost function and trilinear interpolation
(http://www.fmrib.ox.ac.uk/fsl/). This model can only partly ac-
count for nonlinear EPI distortion. A possible way around this
problem is tract-based registration; however, for this study, we
had no flip angle data available. To obtain NABT masks, WMH
were masked out and nonbrain tissue was removed with a brain
extraction tool (FSL, FMRIB Analysis Group). To reduce partial
volume effects at the border of WMH, the WMH masks were dilated by
1 pixel before NABT masks were generated. Likewise, WMH masks
were eroded by 1 pixel when determining lesional ADC.
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For assessing WBT and NABT, we used a histogram analysis and
calculated the relative peak height, the peak position, and the average
ADC. To correct for differences in individual brain volumes, the
histograms were normalized by the total number of voxels included
in the histogram analysis. For the assessment of WMH we calculated
the mean ADC.
To assess brain atrophy, 1 observer (R.S.) rated ventricular and
sulcal atrophy separately by using a template-based rating scale
ranging from 1 (no atrophy) to 8 (severe atrophy). The sum of both
ratings was used as a global measure of atrophy. This template also
has been used in previous publications of the study group.18,19
Intrarater reliability was assessed on the basis of double readings of
50 randomly selected scans. Similarly, inter-rater reliability was
assessed from the readings of the same scans by 3 other persons. For
the current observer (R.S.), the intrarater  value was 0.9 for both
sulcal and ventricular atrophy; The inter-rater  value was 0.70 for
sulcal and 0.83 for ventricular atrophy.19
Neuropsychological Testing
Neuropsychological assessment followed the LADIS protocol.20 The
test battery included the Vascular Dementia Assessment Scale
cognitive subscale,21 the Stroop test,22 Trail-Making test.,23 and the
Mini Mental State Examination.24 Vascular Dementia Assessment
Scale cognitive subscale includes all items of the Alzheimer Disease
Assessment Scale25 plus the symbol digit test, the digit span, a maze
test, and tests of digit cancellation and verbal fluency.
We measured cognitive performance by cognitive domains using
standardized results of Vascular Dementia Assessment Scale subtests
for the domains language, constructional abilities, and orientation.
Memory, executive function, and speed were assessed by computing
compound measures from all test results within a given domain. The
Mini Mental State Examination was considered as a measure of
global cognitive function.
Statistical Analysis
We used the Statistical Package for Social Sciences (SPSS 16.0;
SPSS) for data analysis. To allow for direct comparisons of ADC
histogram analyses and of neuropsychological tests results be-
tween centers, we generated z scores. A z score defines where a
score is within the distribution of scores. A z score of 1
corresponds to a score 1 SD above the mean score. The z scores
of neuropsychological tests for which higher scores represented
poorer performance were inverted (z) for calculation of com-
pound measure scores.
The memory score was the sum of the z scores of immediate word
recall (inverted) plus delayed word recall (inverted) plus word
recognition (inverted) plus digit span. Executive functions were
represented by the sum of z scores of Stroop 3 to 2 (inverted) plus
Trail-Making test B minus Trail-Making test A (inverted) plus
symbol digit score plus verbal fluency.
The speed score was the sum of the z scores of Trail-Making test
A (inverted) plus maze (inverted) plus digit cancellation. The results
of the Mini Mental State Examination were also transferred to z
scores.
Categorical variables among the white matter lesion grades were
compared by the 2 test. Assumption of normal distribution for
continuous variables was assessed by Lilliefors statistics. Normally
distributed continuous variables were compared by 1-way analysis of
variance, whereas the Kruskal-Wallis test was used for comparison
of non-normally distributed variables. Multivariate regression anal-
ysis assessed the relative contribution of ADC measures on perfor-
mance in different cognitive domains. Regression analyses were
adjusted in 3 models.
Model 1 included gender, age, years of education, center, hyper-
tension, diabetes, and cardiac disease. Model 2 extended model 1 by
the addition of white matter lesion volume and model 3 extended
model 2 by the addition of the brain atrophy score. Analyses were
performed on the entire cohort and by center.
Results
Eight centers of the LADIS consortium contributed a total of
340 patients with DWI scans. The number of patients per
center ranged from 20 to 61. Table 1 describes the patient
characteristics for the whole group and are broken down by
WMH grade.
The subgroup taking part in the ADC study did not
significantly differ from the entire LADIS cohort with respect
to age, gender, education, frequency of vascular risk factors,
and WMH scores.26 As can be seen from Table 1, increasing
WMH scores were associated with higher frequency of
hypertension, a greater WMH volume, more brain atrophy,
and worse overall cognitive performance. Executive func-
tions and speed were most affected. Increasing WMH sever-
ity also related to significant changes in the ADC histogram
metrics of WBT, NABT, and in the mean ADC of WMH
(Table 1). Specifically, mean ADC and ADC peak position
increased in WBT and NABT, whereas ADC peak height
decreased. Mean ADC of WMH increased with higher WMH
scores.
The ADC in areas of WMH correlated with ADC measures
in WBT (mean ADC, r0.37; P0.0001; peak height,
r0.33; P0.0001; peak position, r0.50; P0.0001) and
NABT (mean ADC, r0.38; P0.0001; peak height,
r0.34; P0.0001; peak position, r0.49, P0.0001). When
assessing the relation between ADC metrics in WBT, NABT,
and the mean ADC of WMH with cognitive performance,
significant associations were seen with scores assessing
memory, executive function, and speed of performance (Ta-
ble 2). No associations were seen with test results on
language, constructional abilities, and orientation. As can be
seen in Table 2, associations with performance in tests of
memory, executive function, and speed with ADC histogram
metrics were similarly strong whether obtained from WBT or
NABT, whereas the associations with mean ADC of WMH
were only marginal for memory and speed and lost signifi-
cance after correction for WMH volume (model 2). In model
3, which adjusted for age, gender, study center, education,
risk factors, white matter lesion volume, and brain atrophy,
the global mean ADC and peak position of WBT and NABT
remained significantly associated with speed only, whereas
peak height correlated with memory performance, executive
dysfunction, and speed. The associations between relative
peak height in WBT and NABT and memory, executive
functioning, and speed were consistent among centers. This is
illustrated for NABT in the Figure. In the fully adjusted
model, lower Mini Mental State Examination scores also
correlated significantly with lower peak height in WBT
(0.19; SE, 0.09; P0.02) and in NABT (0.19; SE,
0.08; P0.02).
Discussion
In this large multicenter study in subjects with various
degrees of age-related WMH, we found that ADC indices in
unsegmented WBT related to executive dysfunction, slower
processing speed, and memory impairment, a pattern that has
been implicated with leukoariosis.1,27,28 The associations
were also reflected on Mini Mental State Examination results,
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presenting a global measure of cognitive functioning. Our
analyses in segmented brain tissue clearly demonstrate that
changes in mean diffusivity of NABT are responsible for
cognitive dysfunction. This is supported by the fact that mean
ADC of WMH was not related to poorer test performance
whereas significant associations existed with ADC measures
of segmented NABT after masking WMH. The associations
between ADC metrics in NABT and cognitive functioning
remained preserved despite adjustment for WMH volume. At
first glance this appears in contradiction with reportedly
worse neuropsychologic test results with increasing WMH
severity and the assumption of more extensive tissue destruc-
tion in higher WMH grades, which is supported by an
increase in diffusivity.6,26 However, WMH severity seem-
ingly relates not only to lesional mean ADC but also to ADC
histogram metrics of NABT. Not surprisingly, the integrity of
NABT constituting a much larger portion of the brain than the
WMH volume is likely to have more impact on brain
functioning and correlations with neuropsychologic variables
were quite similar whether WMH were included (WBT) or
not (NABT). Whether changes in NABT are directly related
to WMH severity or a parallel phenomenon caused by the
same upstream parameters still remains to be clarified. By all
means, the close relationship between WMH grading and
DWI findings in NABT suggests WMH severity as seen on
conventional MRI to be an indirect marker of NABT
integrity.
Furthermore, our findings indicate that the integrity of
NABT as reflected by histogram metrics contributes to
cognitive impairment of subjects with WMH independent of
brain atrophy. There is only 1 other study29 that corrected the
association between diffusion imaging variables and cogni-
tive functioning for both WMH lesion load and brain atrophy.
These authors29 also described that diffusivity in normal-
appearing white matter was more strongly related to cogni-
tion than WMH volume and atrophy, and they also found
Table 1. Patient Characteristics, MRI Measures, and Cognitive Findings
Characteristic Whole Group (n340) WMH Grade 1 (n155) WMH Grade 2 (n108) WMH Grade 3 (n77) P
Age, yr 73.95.1 73.35.1 74.15.3 74.84.7 0.09
Female 183 (53.8%) 82 (52.9%) 66 (61.1%) 35 (45.5%) 0.10*
Years of education 10.04.1 10.04.2 10.24.2 9.84.3 0.74§
Hypertension 238 (70%) 91 (58.7%) 80 (74.1%) 67 (87.0%) 0.001*
Diabetes 47 (13.8%) 19 (12.3%) 16 (14.8%) 12 (15.6%) 0.74*
Atrial fibrillation 25 (7.4%) 8 (5.2%) 10 (9.3%) 7 (9.1%) 0.36*
Myocardial infarction 47 (13.8%) 22 (14.2%) 12 (11.1%) 13 (16.9%) 0.53*
WMH volume, cm‡ 20.221.0 6.45.0 19.19.5 49.823.6 0.001§
Brain atrophy score 8.12.6 7.32.5 8.42.7 9.32.3 0.001‡
Cognition (z scores)
Memory 0.040.69 0.110.66 0.000.72 0.030.71 0.26†
Executive function 0.130.7 0.250.66 0.180.64 0.180.79 0.001†
Speed 0.040.83 0.210.73 0.050.72 0.311.03 0.001§
Construction 0.500.73 0.450.58 0.590.93 0.500.68 0.80§
Language 0.170.43 0.140.44 0.120.33 0.290.51 0.01§
Orientation 0.391.21 0.220.96 0.541.50 0.531.21 0.06§
Mini Mental State Examination 27.542.33 27.881.95 27.462.46 27.062.77 0.06
Apparent diffusion coefficient (z scores)
Whole brain tissue (WBT) ADC
Mean§ 0.00.99 0.240.95 0.061.00 0.390.91 0.001†
Peak height¶ 0.00.99 0.290.97 0.08094 0.480.88 0.001†
Peak position 0.00.99 0.330.89 0.120.92 0.511.03 0.001†
NABT ADC
Mean§ 0.00.99 0.230.96 0.051.00 0.380.91 0.001†
Peak height¶ 0.00.99 0.300.97 0.070.93 0.510.89 0.001†
Peak position 0.00.99 0.340.87 0.120.94 0.521.02 0.001†
WMH ADC
Mean§ 0.00.99 0.280.97 0.030.87 0.610.94 0.001†
* test.
†ANOVA.
‡Kruskal-Wallis test.
§Higher values indicates higher diffusivity in the analyzed tissue compartment.
¶Lower values indicate less tissue with normal diffusivity values in the analyzed tissue compartment.
A shift to higher values indicates a global increase of diffusivity in the analyzed tissue compartment.
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associations not only with executive dysfunction but also
with performance on memory tasks.
ADC has been considered as a measure of white matter
integrity,30 but only the relative peak height of the ADC
histogram in NABT was consistently and strongly related to
cognitive performance, whereas no such relationships existed
with peak position or mean ADC. The main contribution to
the ADC histogram of NABT comes from white matter,
which largely governs the peak position and the peak height.
The relative peak height reflects the number of voxels in
normal-appearing white matter in relation to the total number
of voxels contributing to the histogram. Any change in tissue
composition will inevitably change peak height. Brain atro-
phy, which is known to occur with white matter disease,31 has
a substantial impact on peak height, but our analyses were
corrected for atrophy. Consequently, the most likely expla-
Table 2. Associations Between ADC Histogram Metrics in Whole Brain Tissue (WBT), Normal Appearing Brain Tissue (NABT), Mean
ADC of WMH and Cognitive Performance (Only Domains With Significant Associations are Shown)
Cognitive Function
WBT NABT
WMH
Mean ADC
Mean
Global ADC Peak Height
Peak
Position
Mean Global
ADC Peak Height
Peak
Position
Memory
Model 1
 0.12 0.14 0.06 0.12 0.15 0.06 0.07
SE 0.04 0.04 0.04 0.04 0.04 0.04 0.04
P 0.02 0.0001 0.12 0.001 0.001 0.12 0.002
Model 2
 0.11 0.15 0.05 0.11 0.16 0.05 0.06
SE 0.04 0.04 0.04 0.04 0.04 0.04 0.04
P 0.005 0.0001 0.23 0.004 0.0001 0.24 0.1
Model 3
 0.11 0.19 0.04 0.11 0.21 0.03 0.06
SE 0.06 0.05 0.05 0.06 0.06 0.05 0.05
P 0.07 0.001 0.45 0.06 0.0001 0.5 0.2
Executive function
Model 1
 0.07 0.11 0.08 0.08 0.12 0.09 0.04
SE 0.04 0.04 0.04 0.04 0.04 0.04 0.04
P 0.06 0.002 0.02 0.04 0.001 0.01 0.22
Model 2
 0.04 0.08 0.04 0.04 0.09 0.05 0.004
SE 0.04 0.04 0.04 0.04 0.04 0.04 0.04
P 0.30 0.03 0.26 0.26 0.02 0.22 0.92
Model 3
 0.006 0.12 0.02 0.005 0.13 0.002 0.01
SE 0.05 0.05 0.05 0.05 0.05 0.02 0.02
P 0.91 0.02 0.63 0.92 0.01 0.89 0.76
Speed
Model 1
 0.21 0.21 0.18 0.21 0.21 0.17 0.11
SE 0.04 0.04 0.04 0.05 0.04 0.04 0.04
P 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 0.01
Model 2
 0.19 0.18 0.14 0.19 0.17 0.13 0.06
SE 0.05 0.05 0.05 0.05 0.05 0.05 0.05
P 0.0001 0.0001 0.002 0.0001 0.0001 0.005 0.22
Model 3
 0.18 0.23 0.13 0.15 0.21 0.11 0.02
SE 0.06 0.05 0.05 0.06 0.06 0.05 0.05
P 0.002 0.0001 0.008 0.01 0.0001 0.03 0.62
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nation for the observed associations between cognition and
ADC peak height are focal alterations of tissue composition
or structure in the normal-appearing white matter. Diffuse
white matter changes would have resulted in changes of peak
position, which indicates the ADC of the largest contributing
tissue component. Thus, these findings can add to our
etiologic understanding of age-related white matter damage
because they argue against a diffuse pathological process as
the origin of WHM. They support the view that both visible
and invisible microstructural small-vessel disease-related
damage in the aging brain is focal, with invisible abnormal-
ities being a crucial factor in the evolution of cognitive
impairment.32,33 Whether these abnormalities precede WMH
or are a consequence of the same pathogenic mechanisms or
even occur secondarily to WMH cannot be resolved with this
study but should be explored in the future.
A strength of our study is the large sample size with an
equal distribution of subjects with various grades of
WMH. This is different from population-based samples in
which the most severe grades of WMH are often
under-represented.
A limitation of the study is that ADC values come from
diffusion weighting in only 3 independent directions and
represent measures of mean diffusivity. Because diffusion is
not an isotropic process in neuronal tissue, a more detailed
diffusion analysis could have been expected from diffusion
tensor imaging with at least 6 independent directions of the
diffusion gradient. This would have allowed additional as-
sessment of radial and axial diffusivity and, subsequently,
fractional anisotropy, although interpretation of radial and
axial diffusivity in terms of underlying tissue structure is not
necessarily straightforward.34 Unfortunately, the acquisition
of such data was not possible in all centers at the start of the
LADIS study.
Another limitation is that we did not segment gray and
white matter separately. Reliable segmentation can only be
performed with conventional MRI scans with adequate con-
trast and resolution and with a nonlinear registration tech-
nique. Because these conditions were not fulfilled in the
current multicenter setting, we refrained from segmentation
to avoid misclassification errors and introduction of noise
into the histogram analysis. It is important to point out,
however, that although the histogram analysis was performed
for NABT, this analysis mainly provides information on
normal-appearing white matter, simply because it drives the
histogram peak representing white matter. Our study is
cross-sectional and interpretation of current results regarding
cause and effect is limited.
Conclusion
In conclusion, DWI studies like ours clearly direct further
research in the field of age-related brain damage toward
ultrastructural abnormalities of NABT because they have
now been consistently shown to more closely relate to the
actual cognitive function of older persons than the amount of
tissue destruction visible in standard MR acquisitions. In this
context DWI adds not only to the potential for quantitative
assessment of tissue changes but also allows the appreciation
Figure. Associations between relative peak height in NABT and memory, executive functioning, and speed in participating centers.
Multiple linear regression analysis between z scores of NABT and cognitive domains adjusted for gender, age, years of education,
hypertension, diabetes, cardiac disease, volume of white matter lesions, and brain atrophy score by center. Dot on x-axis indicates 
coefficient and line indicates 95% confidence interval. There is a direct relationship between peak height of NABT and performance in
the 3 cognitive domains. The association of combined results was significant and the direction of the associations was largely consis-
tent among centers.
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of changes of the entire brain, and thus of a much larger
portion of cerebral tissue than WMH, which are conse-
quences of or evolve in parallel to WMH. Any interventional
trial attempting to ameliorate the clinical consequences of
progressing WMH should also include DWI as an outcome
measure, which can be reliably accomplished on a multi-
center basis as shown by our results.
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